Regulations.gov document
Bioavailability Studies Submitted in NDAs or INDs — General Considerations; Guidance for…
Other · FDA-2018-D-4367 · posted Feb 26, 2019
Key facts
| Document ID | FDA-2018-D-4367-0003 |
|---|---|
| Title | Bioavailability Studies Submitted in NDAs or INDs — General Considerations; Guidance for Industry; Draft Guidance |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2018-D-4367 |
| Posted | Feb 26, 2019 |
| Comment period opens | Feb 26, 2019 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: